Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Benjamin L. Maughan
Journal Article
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating “BRCAness” Genotype (ROAR)
The Oncologist, Volume 29, Issue 5, May 2024, Pages 450–e725, https://doi.org/10.1093/oncolo/oyae030
Published: 07 March 2024
Journal Article
Impact of Time to Metastasis (Synchronous vs. Metachronous) on Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with First Line Immune-Checkpoint Inhibitors (ICI)-based Combinations
The Oncologist, Volume 28, Issue Supplement_1, September 2023, Pages S9–S10, https://doi.org/10.1093/oncolo/oyad216.014
Published: 23 August 2023
Journal Article
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma
The Oncologist, Volume 28, Issue 8, August 2023, Pages 737–e693, https://doi.org/10.1093/oncolo/oyad019
Published: 23 March 2023
Journal Article
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
The Oncologist, Volume 27, Issue 10, October 2022, Pages e815–e818, https://doi.org/10.1093/oncolo/oyac176
Published: 29 August 2022
Journal Article
Radium-223 Plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results
The Oncologist, Volume 26, Issue 12, December 2021, Pages 1006–e2129, https://doi.org/10.1002/onco.13949
Published: 23 September 2021
Journal Article
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform
The Oncologist, Volume 26, Issue 9, September 2021, Pages 751–760, https://doi.org/10.1002/onco.13869
Published: 07 July 2021
Journal Article
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer
The Oncologist, Volume 26, Issue 2, February 2021, Pages e270–e278, https://doi.org/10.1002/onco.13601
Published: 03 December 2020
Journal Article
A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
The Oncologist, Volume 25, Issue 2, February 2020, Pages 121–e213, https://doi.org/10.1634/theoncologist.2019-0599
Published: 06 September 2019
Journal Article
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial
The Oncologist, Volume 23, Issue 12, December 2018, Pages 1413–e151, https://doi.org/10.1634/theoncologist.2018-0652
Published: 01 November 2018
